Dyadic Company Description
Don't confuse Coca-Cola's C2 with Dyadic International's C1: One is an attempt by an aging cola company to cash in on the low-carbohydrate trend, while the other is a technology using Chrysosporium lucknowense fungus to profit from the demand for protein. Therapeutic proteins, that is. Dyadic International uses its C1 Expression System for a variety of life sciences and industrial applications. The firm's enzyme business makes enzymes and other biological products for commercial and industrial uses employing C1 know-how. Dyadic's biopharma division uses the expression system to make therapeutic proteins for drugmakers. The company is also developing its enzymes for bioenergy applications.
View the Comprehensive Company Description for Dyadic
The Company Description provides a historical perspective of Dyadic's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Dyadic's evolution in the marketplace.
